1. Rehrig, S., S. D. Fleming, J. Anderson, J. M. Gutheridge, J. Rakstang, C. McQueen, V. M. Holers, G. C. Tsokos, and T. Shea-Donohue. 2001. Complement inhibitor, Crry-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice. J. Immunol. 167:5921-5927.

2. Eror, A. T., A. Stojadinovic, B. W. Starnes, S. C. Makrides, G. C. Tsokos, and T. Shea-Donohue.1999. Anti-inflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine. Clin. Immunol. 90:266-275.

3. Conner, W. C., C. M. Gallagher, T. J. Miner, H. Tavaf-Motamen, K. M. Wolcott, and T. Shea-Donohue. 1999. Neutrophil priming state predicts capillary leak after gut ischemia in rats. J. Surg. Res. 84:24-30.

4. Kilgore, K. S., R. F. Todd, and B. R. Lucchesi. 1999. Reperfusion injury. In Inflammation:basic principles and clinical correlates. J. I. Gallin, and R. Snyderman, eds. Lippincott Williams and Wilkins, Philadelphia, p. 1047-1060.

5. D'Ambrosio, A. L., D. J. Pinsky, and E. S. Connolly. 2001. The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection. Mol. Med. 7:367-382.

6. Fleming, S. D., S. T. Rehrig, J. M. Guthridge, T. Shea-Donohue, G. C. Tsokos, and V. M. Holers. 2000. Role of CR2- and CD19-regulated natural antibodies in intestinal ischemia reperfusion-induced injury. Immunopharmacol. 49:22.

7. Stahl, G. L., Y. Xu, L. Hao, M. Miller, J. A. Buras, M. Fung, and H. Zhao. 2003. Role for the alternate complement pathway in ischemia/reperfusion injury. Am. J. Pathol. 162:449-455.

8. Williams, J. P., T. T. V. Pechet, M. R. Weiser, R. Reid, L. Kobzik, F. D. Moore, M. C. Carroll, and H. B. Hechtman. 1999. Intestinal reperfusion injury is mediated by IgM and complement. Journal of Applied Physiology 86:938-942.

9. Austen, W. G., C. Kyriakides, J. Favuzza, Y. Wang, L. Kobzik, F. D. Moore, and H. B. Hechtman. 1999. Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex. Surgery 126:343-348.

10. Hill, J., T. F. Lindsay, F. Ortiz, C. G. Yeh, H. B. Hechtman, and F. D. Moore. 1992. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J. Immunol. 149:1723-1728.

11. Fleming, S. D., J. Anderson, F. Wilson, T. Shea-Donohue, and G. C. Tsokos. 2003. C5 is required for CD49d expression on neutrophils and VCAM expression on vascular endothelial cells following mesenteric ischemia/reperfusion. Clin. Immunol. 105:55-64.

12. Ward, D. T., S. A. Lawson, C. M. Gallagher, W. C. Conner, and T. Shea-Donohue. 2000. Sustained nitric oxide production via L-Arginine administration ameliorates effects of intestinal ischemia-reperfusion. J. Surg. Res. 89:13-19.

13. Kohl, J. 2001. Anaphylatoxins and infections and non-infectious inflammatory diseases. Mol. Immunol. 38:175-187.

14. Wada, K., M. C. Montalto, and G. L. Stahl. 2001. Inhibition of complement C5 reduces local and remote organ injury after intestinal ishcmenia/reperfusion in the rat. Gastroent. 120:126-133.

15. Fleming, S. D., D. Mastellos, G. Karpel-Massler, T. Shea-Donohue, J. D. Lambris, and G. C. Tsokos. 2003. C5a-mediated mesenteric ischemia/reperfusion injury is independent of polymorphonuclear neutrophils. Clin. Immunol 108:263-273.

16. Wang, Y., S. A. Rollins, J. A. Madri, and L. A. Matis. 1995. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proceeding of the National Academy of Sciences USA 92:8955-8959.

17. Vakeva, A. P., A. Agah, S. A. Rollins, L. A. Matis, L. Li, and G. L. Stahl. 1998. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 97:2259-2267.

18. Vakeva, A., and S. Meri. 1998. Complement activation and regulator expression after anoxic injury of human endothelial cells. APMIS 106:1149-1156.

19. Rinder, C. S., H. M. Rinder, B. R. Smith, J. C. K. Fitch, M. J. Smith, J. B. Tracey, L. A. Matis, S. P. Squinto, and S. A. Rollins. 1995. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation duringextracorporeal circulation. J. Clin. Invest. 96:1564-1572.

20. Fleming, S. D., T. Shea-Donohue, J. M. Guthridge, L. Kulik, T. J. Waldschmidt, M. G. Gipson, G. C. Tsokos, and V. M. Holers. 2002. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J. Immunol. 169:2126-2133.

21. Fosse, E., J. Pillgram-Larsen, J. Svennevig, C. Nordby, A. Skulberg, T. E. Mollnes, and M. Abdelnoor. 1998. Complement activation in injured patients occurs immediately and is dependent on the severity of the trauma. Injury 29:509-514.

22. Goris, R. J. A. 2000. Pathophysiology of shock in trauma. Eur. J. Surg. 166:100-111.

23. Gallinaro, R., W. G. Cheadle, K. Applegate, and H. C. Polk. 1992. The role of the complement system in trauma and infection. Surgery 174:435-440.

24. Mollnes, T. E., H.-J. Haga, J. G. Brun, E. W. Nielsen, A. Sjoholm, G. Sturfeldt, U. Martensson, K. Bergh, and O. P. Rekvig. 1999. Complement activation in patients with sytemic lupus erythematosus without nephritis. Rheumatology 38:933-940.

25. Fruchterman, T. M., D. A. Spain, M. A. Wilson, P. D. Harris, and R. N. Garrison. 1998. Complement inhbition prevents gut ischemia and endothelial cell dysfunction after hemorrhage/resuscitation. Surgery 124:782-792.

26. Weiser, M. R., T. T. Pehet, J. P. Williams, M. Ma, P. S. Frenette, F. D. Moore, L. Kobzik, R. O. Hines, D. D. Wagner, M. C. Carroll, and H. B. Hechtman. 1997. Experimental murine acid aspiration injury is mediated by neutrophils and the alternative complement pathway. Journal of Applied Physiology 83:1090-1095.

27. Zhou, W., C. A. Farrar, K. Abe, J. R. Pratt, J. E. Marsh, Y. Wang, G. L. Stahl, and S. H. Sacks. 2000. Predominant role of C5b-9 in renal ischemia/reperfusion injury. J. Clin. Invest. 105:1363-1371.

28. Collard, C. D., R. Lekowski, J. E. Jordan, A. Agah, and G. L. Stahl. 1999. Complement activation following oxidative stress. Mol. Immunol. 36:941-948.

29. Jordan, J. E., M. C. Montalto, and G. L. Stahl. 2001. Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury. Circulation 104:1413-1418.

30. Wetsel, R. A., J. Kildsgaard, and D. L. Haviland. 2000. Complement anaphylatoxins (C3a, C4a, C5a) and their receptors (C3aR, C5aR/CD88) as therapeutic targets in inflammation. In Therapeutic interventions in the complement system. J. D. Lambris, and V. M. Holers, eds. Humana Press, Totowa, NJ, p.113-153.

31. Perianayagam, M. C., V. S. Balakrishnan, A. J. King, B. J. G. Pereira, and B. L. Jaber. 2002. C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. Kidney International 61:456-463.

32. Tyagi, S., L. B. Klickstein, and A. Nicholson-Weller. 2000. C5a-stimulated human neutrophils use a subset of integrins to support the adhesion-dependent phase of superoxide production. Journal of Leukocyte Biology 68:679-686.

33. Binder, R., A. Kress, G. Kan, K. Hermann, and M. Kirschfink. 1999. Neurtophil priming by cytokines and vitamin D binding protein (Gc-globulin): impact on C5a-mediated chemotaxis, degranulation and respiratory burst. Mol. Immunol. 36:885-892.

34. Tofukuji, M., G. L. Stahl, C. Metais, M. Tomita, A. Agah, c. Bianchi, M. P. Fink, and F. W. Sellke. 2000. Mesenteric dysfunction after cardiopulmonary bypass: role of complement C5a. Ann Thorac. Surg. 69:799-807.

35. Bless, N. M., R. L. Warner, V. A. Padgaonkar, A. B. Lentsch, B. J. Czermak, H. Schmal, H. P. Friedl, and P. A. Ward. 1999. Roles for C-X-C chemokines and C5a in lung injury after hindlimb ischemia-reperfusion. Am. J. Physiol. 276:L57-L63.

36. Huber-Lang, M. S., J. V. Sarma, S. R. McGuire, K. T. Lu, R. F. Guo, V. A. Padgaonkar, E. M. Younkin, I. J. Laudes, N. C. Riedemann, J. G. Younger, and P. A. Ward. 2001.

Protective effects of anti-C5a peptide antibodies in experimental sepsis. FASEB Journal 15:568-570.

37. Huber-Lang, M., J. V. Sarma, K. T. Lu, S. R. McGuire, V. A. Padgaonkar, R. F. Guo, E. M. Younkin, R. G. Kunkel, J. Ding, R. Erickson, J. T. Curnutte, and P. A. Ward. 2001. Role of C5a in multiorgan failure during sepsis. J. Immunol. 166:1193-1199.

38. Riedemann, N. C., and P. A. Ward. 2003. Complement in ischemia reperfusion injury. Am. J. Pathol. 162:363-367.

39. Riedemann, N. C., R. F. Guo, T. A. Neff, I. J. Laudes, K. A. Keller, J. V. Sarma, M. M. Markiewski, D. Mastellos, C. W. Strey, C. L. Pierson, J. D. Lambris, F. S. Zetoune, and P. A. Ward. 2002. Increased C5a receptor expression in sepsis. J. Clin. Invest. 110:101108.

40. Mulligan, M. S., E. Schmid, B. Beck-Schimmer, G. O. Till, H. P. Friedl, R. Brauer, T. E. Hugli, M. Miyasaka, R. L. Warner, K. J. Johnson, and P. A. Ward. 1996. Requirement and role of C5a in acute lung inflammatory injury in rats. J. Clin. Invest. 98:503-512.

41. Rothermel, E., O. Gotze, S. Zahn, and G. Schlaf. 2000. Analysis of the tissue distribution of the rat C5a receptor and inhibition of C5a-mediated effects through the use of two MoAbs. Scand. J. Immunol. 52:401-410.

42. Pellas, T. C., W. Boyar, J. V. Oostrum, J. Wasvary, L. R. Fryer, G. Pastor, M. Sills, A. Braunwalder, D. R. Yarwood, R. Kramer, E. Kimble, J. Hadala, W. Haston, R. Moreira-Ludewig, S. Uziel-Fusi, P. Peters, K. Bill, and L. Wennogle. 1998. Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo. Journal of ImmunologyI 160:5616-5621.

43. Heller, T., M. Hennecke, U. Baumann, J. E. Gessner, A. Meyer zu Vilsendorf, M. Baensch, F. Boulay, A. Kola, A. Klos, W. Bautsch, and J. Kohl. 1999. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury. J. Immunol. 163:985-994.

44. Haynes, D. R., D. G. Harkin, L. P. Bignold, M. J. Hutchens, S. M. Taylor, and D. P. Fairlie. 2000. Inhibition of C5a-induced neutrophil chemotaxis and macrophage cytokine production in vitro by a new C5a receptor antagonist. Biochemical Pharmacology 60:729-733.

45. Arumugam, T. V., I. A. Shiels, T. M. Woodruff, R. C. Reid, D. P. Fairlie, and S. M. Taylor. 2002. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine. J. Surg. Res. 103:260-267.

46. Basta, M. 1996. Modulation of complement-mediated immune damage by intravenous immune globulin. Clin. Exp, Immunol. 104 Suppl.1:21-25.

47. Anderson, J., S. Fleming, M. Basta, G. Tsokos, and T. Shea-Donohue. 2001. Intravenous immunoglobulin (IVIG) attenuates mesenteric ischemia/reperfusion injury in rats. Gastroenterology 120:A195.

48. Anderson, J., S. Fleming, G. Tsokos, C. Swiecki, and T. Shea-Donohue. 2002. Intravenous immunoglobulin (IVIG) protects against the development of systemic injury following mesenteric ischemia/reperfusion. Gastroent. (in press).

49. Anderson., J., S. Rehrig, S. Fleming, M. Basta, G. Tsokos, and T. Shea-Donohue. 2001. Intravenous immunoglobulin attenuates mesenteric ischemia-reperfusioninjury. Clin. Immunol. 99:170.

50. Sahu, A., D. Morikis, and J. D. Lambris. 2003. Compstatin, a peptide inhibitor of complement, exhibits species specific binding to complement component C3. Mol. Immunol. 39:557-566.

51. Karpel-Massler, G., S.D. Fleming, M. Kirschfink, and G.C. Tsokos, 2003. Human C1 esterase inhibitor attenuates murine mesenteric ischemia/reperfusion induced local organ injury. J. Surg. Res. 115:247-256.

Was this article helpful?

0 0
How To Win Your War Against Allergies

How To Win Your War Against Allergies

Not Able To Lead A Happy Life Because Of Excessive Allergies? Want To Badly Get Rid Of Your Allergy Problems, But Are Super Confused And Not Sure Where To Even Start? Don't Worry, Help Is Just Around The Corner Revealed The All-In-One Power Packed Manual Containing Ample Strategies And Little-Known Tips To Get Rid Of Any Allergy Problems That Are Ruining Your Life Learn How You Can Eliminate Allergies Completely Reclaim Your Life Once Again

Get My Free Ebook

Post a comment